Epitomee Medical Ltd (TLV:EPIT)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
903.00
+21.90 (2.49%)
Jul 23, 2025, 1:27 PM IDT
2.49%
Market Cap262.64M
Revenue (ttm)n/a
Net Income (ttm)-5.33M
Shares Out29.81M
EPS (ttm)-0.18
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6,196
Average Volume27,977
Open881.10
Previous Close881.10
Day's Range881.10 - 914.90
52-Week Range249.40 - 1,570.00
Beta0.77
RSI52.03
Earnings DateAug 14, 2025

About Epitomee Medical

Epitomee Medical Ltd, a biomedical company, develops and commercializes ingestible therapeutic devices worldwide. Its capsule is used for weight management, waist circumference reduction, and cardiovascular risk factors reduction. Epitomee Medical Ltd has a strategic partnership with Nestlé Health Science S.A. for the development and commercialization of the weight loss capsule. The company was incorporated in 2005 and is based in Caesarea, Israel. [Read more]

Sector Healthcare
Founded 2005
Employees 42
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol EPIT
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.